JP2000514427A - フィブリノーゲンレセプター拮抗薬プロドラッグ - Google Patents

フィブリノーゲンレセプター拮抗薬プロドラッグ

Info

Publication number
JP2000514427A
JP2000514427A JP10504262A JP50426298A JP2000514427A JP 2000514427 A JP2000514427 A JP 2000514427A JP 10504262 A JP10504262 A JP 10504262A JP 50426298 A JP50426298 A JP 50426298A JP 2000514427 A JP2000514427 A JP 2000514427A
Authority
JP
Japan
Prior art keywords
alkyl
aryl
carboxy
alkyloxy
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP10504262A
Other languages
English (en)
Japanese (ja)
Inventor
エグバートソン，メリツサ・エス
ハートマン，ジヨージ・デイー
ラマ，ウイリアム・シー
ウエイ，ジヨン・エス
ヤング，ステイーブン・デイー
Original Assignee
メルク エンド カンパニー インコーポレーテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9617983.3A external-priority patent/GB9617983D0/en
Application filed by メルク エンド カンパニー インコーポレーテッド filed Critical メルク エンド カンパニー インコーポレーテッド
Publication of JP2000514427A publication Critical patent/JP2000514427A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205—Radicals derived from carbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/70—Sulfur atoms
    • C07D213/71—Sulfur atoms to which a second hetero atom is attached
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP10504262A 1996-06-28 1997-06-25 フィブリノーゲンレセプター拮抗薬プロドラッグ Pending JP2000514427A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US2097696P 1996-06-28 1996-06-28
GB9617983.3 1996-08-28
GB60/020,976 1996-08-28
GBGB9617983.3A GB9617983D0 (en) 1996-08-28 1996-08-28 Fibrinogen receptor antagonist prodrugs
PCT/US1997/011037 WO1998000144A1 (fr) 1996-06-28 1997-06-25 Promedicaments antagonistes du recepteur de fibrinogene

Publications (1)

Publication Number Publication Date
JP2000514427A true JP2000514427A (ja) 2000-10-31

Family

ID=26309939

Family Applications (1)

Application Number Title Priority Date Filing Date
JP10504262A Pending JP2000514427A (ja) 1996-06-28 1997-06-25 フィブリノーゲンレセプター拮抗薬プロドラッグ

Country Status (5)

Country Link
EP (1) EP0912182A4 (fr)
JP (1) JP2000514427A (fr)
AU (1) AU709631B2 (fr)
CA (1) CA2257937A1 (fr)
WO (1) WO1998000144A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008516897A (ja) * 2004-10-01 2008-05-22 イステイチユート・デイ・リチエルケ・デイ・ビオロジア・モレコラーレ・ピ・アンジエレツテイ・エツセ・ピー・アー Ｈｃｖ複製の調節
JP2008545770A (ja) * 2005-06-06 2008-12-18 エフ．ホフマン−ラ ロシュ アーゲー 肝臓のカルニチンパルミトイルトランスフェラーゼ（ｌ−ｃｐｔ１）阻害剤として有用なスルホンアミド誘導体

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU721130B2 (en) * 1996-06-28 2000-06-22 Merck & Co., Inc. Fibrinogen receptor antagonists
NL1006179C2 (nl) * 1997-05-30 1998-12-01 Alcoa Nederland Bv Werkwijze voor het verwerken van materiaal uit aluminium en kunststof.
GB0319150D0 (en) * 2003-08-14 2003-09-17 Glaxo Group Ltd Novel compounds
AU2007221207A1 (en) 2006-02-28 2007-09-07 Merck Sharp & Dohme Corp. Inhibitors of histone deacetylase
DK2825541T3 (en) 2012-03-16 2016-10-03 Vitae Pharmaceuticals Inc LIVER-X-receptor modulators
BR112014022780A8 (pt) 2012-03-16 2021-06-15 Vitae Pharmaceuticals Inc composto modulador de receptor de fígado x, composição farmacêutica que o compreende e seu uso
CN107501202A (zh) * 2017-09-26 2017-12-22 杨文浪 微波法制备1,4苯并噁嗪酮的合成工艺

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256812A (en) * 1989-01-31 1993-10-26 Hoffmann-La Roche Inc. Carboxamides and sulfonamides
GB9406143D0 (en) * 1993-03-29 1994-05-18 Zeneca Ltd Heterocyclic derivatives
CA2155307A1 (fr) * 1993-03-29 1994-10-13 Michael Garth Wayne Composes heterocycliques, inhibiteurs de l'agregation des plaquettes
US5547671A (en) * 1995-09-20 1996-08-20 Duthinh; Phu Anti-intoxication composition

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008516897A (ja) * 2004-10-01 2008-05-22 イステイチユート・デイ・リチエルケ・デイ・ビオロジア・モレコラーレ・ピ・アンジエレツテイ・エツセ・ピー・アー Ｈｃｖ複製の調節
JP2008545770A (ja) * 2005-06-06 2008-12-18 エフ．ホフマン−ラ ロシュ アーゲー 肝臓のカルニチンパルミトイルトランスフェラーゼ（ｌ−ｃｐｔ１）阻害剤として有用なスルホンアミド誘導体
JP4880678B2 (ja) * 2005-06-06 2012-02-22 エフ．ホフマン−ラ ロシュ アーゲー 肝臓のカルニチンパルミトイルトランスフェラーゼ（ｌ−ｃｐｔ１）阻害剤として有用なスルホンアミド誘導体

Also Published As

Publication number Publication date
WO1998000144A1 (fr) 1998-01-08
CA2257937A1 (fr) 1998-01-08
EP0912182A1 (fr) 1999-05-06
EP0912182A4 (fr) 1999-12-29
AU709631B2 (en) 1999-09-02
AU3503397A (en) 1998-01-21

Similar Documents

Publication Publication Date Title
JP2000513375A (ja) フィブリノーゲンレセプター拮抗薬プロドラッグ
US5227490A (en) Fibrinogen receptor antagonists
US5854245A (en) Fibrinogen receptor antagonists
AU712082B2 (en) Fibrinogen receptor antagonists
JP2000514061A (ja) フィブリノーゲン受容体拮抗物質
JP2000516197A (ja) インテグリンレセプターアンタゴニスト
CA2251017A1 (fr) Antagonistes du recepteur .alpha.v.beta.3
JPH05208974A (ja) 新規イソキノリンスルホンアミド
WO2003002554A1 (fr) Composes de piperazine
US5932582A (en) Fibrinogen receptor antagonist prodrugs
EP1472224B1 (fr) 3-alkanoylamino-acide propionique dérivés utilisés comme inhibiteurs de l'intégrine avss6
US5340798A (en) Fibrinogen receptor antagonists
JP2000514427A (ja) フィブリノーゲンレセプター拮抗薬プロドラッグ
US5925655A (en) αv β3 antagonists
US5358956A (en) Fibrinogen receptor antagonists
US5990107A (en) Fibrinogen receptor antagonist prodrugs
JP2001512439A (ja) 線維素原受容体拮抗薬プロドラッグ
US5494921A (en) Fibrinogen receptor antagonists
US5525617A (en) Fibrinogen receptor antagonists
AU742197B2 (en) Fibrinogen receptor antagonists
US5789421A (en) Fibrinogen receptor antagonist
US5889023A (en) Fibrinogen receptor antagonist
US5945545A (en) Fibrinogen receptor antagonists
JPH11513980A (ja) 線維素原受容体拮抗薬
JPH09512836A (ja) 細胞付着抑制剤としての（−）−（３ｒ）−３−メチル−４−｛４−［４−（４−ピリジル）ピペラジン−１−イル］フェノキシ｝酪酸